500 filings
Page 16 of 25
6-K
kym41uz9nvo8ou84t
16 Mar 22
2021 Annual Report A nn ua l R ep or t 20 21
4:55pm
6-K
j189acjhe jvy
15 Mar 22
Current report (foreign)
4:12pm
6-K
itnk12uq2on g5wnmm5s
11 Mar 22
Conference Call Alert
6:04am
6-K
xkm5w6ouo csp5
10 Mar 22
Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014
11:21am
6-K
v3vx7tf2omwrbj6qjwlp
25 Jan 22
MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards’ Gender Equality Index Report
7:16am
6-K
8v2ysy6dk u46
11 Jan 22
Current report (foreign)
10:08am
6-K
wrzbqemlpp2s5
10 Jan 22
MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference
12:34pm
6-K
92torun lz
7 Jan 22
MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
6:39am
6-K
lrq085io
13 Dec 21
MorphoSys presents latest data from the Phase 2 MANIFEST Study evaluating the potential of pelabresib in the treatment of myelofibrosis
10:14am
6-K
vwwneqm2xwt56d
13 Dec 21
Current report (foreign)
9:56am
6-K
ogxfnsryxd
7 Dec 21
Current report (foreign)
6:01am
6-K
vcxhc6
29 Nov 21
Current report (foreign)
4:09pm
6-K
1hlx7f
26 Nov 21
Current report (foreign)
8:15am
6-K
c1emomfxct 2a
23 Nov 21
Current report (foreign)
10:32am
6-K
xhsf4txx42ukkim
12 Nov 21
MorphoSys AG Reports First Nine Months and Third Quarter
8:30am
6-K
wb1fws
10 Nov 21
Third Quarter Interim Statement JANUARY – SEPTEMBER
4:05pm
6-K
owga4vf2tpsul
10 Nov 21
MorphoSys Announces Departure of Roland Wandeler
6:14am
6-K
vo9s5l3g w371sz1af
5 Nov 21
MorphoSys presents interim results from M-PLACE study with felzartamab during American Society of Nephrology Annual Meeting
7:13am
6-K
mgfuv8acdx7r9
4 Nov 21
Current report (foreign)
9:50am
6-K
qw30 sft90nsoxzh
2 Nov 21
Current report (foreign)
11:44am